Pre-market Hot Trades in US Stocks
Novo Nordisk AS pre-market rose 3.20%. According to recent important news:
<ol>
<li>
On September 15, Novo Nordisk AS reported positive results from its high-dose semaglutide trial, with patients averaging a weight loss of 19%, driving the stock price up. Data indicated that the 7.2 mg dose was more effective than the 2.4 mg dose. Source: Jinwu Finance.
</li>
<li>
On September 15, the European Medicines Agency approved an update to the Novo Nordisk oral semaglutide drug label for reducing the risk of cardiovascular death, heart attack, and stroke, further boosting market confidence. Source: Gelonghui.
</li>
<li>
On September 15, analysts maintained a hold rating on Novo Nordisk AS, noting that while the company performed well, it was not listed among the top five recommended buy stocks. Source: MarketBeat. The pharmaceutical industry is highly competitive, with a focus on cardiovascular drugs
</li>
</ol>

Novo Nordisk AS pre-market rose 3.20%; FGI Industries pre-market rose 410.33%; Birks pre-market rose 127.27%; Conifer pre-market rose 90.00%

Pre-market hot trades in US stocks: Novo Nordisk AS pre-market up 3.20%